These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 7951082)

  • 1. [Change of nonspecific bronchial responsiveness and other indices of asthma severity in groups of patients treated with beta2-adrenomimetics "on demand". Test of correlation].
    Brzostek D; Piotrowska B; Droszcz W
    Pneumonol Alergol Pol; 1994; 62(7-8):352-7. PubMed ID: 7951082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of sputum induction on spirometry parameters in patients with bronchial asthma].
    Siergiejko Z; Zietkowski Z; Rogalewska AM
    Pneumonol Alergol Pol; 1999; 67(7-8):318-26. PubMed ID: 10647283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between clinical severity of bronchial asthma and degree of airway inflammation assessed by the eosinophilic leukocyte count in induced sputum].
    Chlumský J; Pokorná H
    Vnitr Lek; 2001 Sep; 47(9):604-8. PubMed ID: 11715664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of nedocromil sodium on the clinical course, ventilatory parameters and nonspecific bronchial hyperreactivity in patients with nonatopic bronchial asthma treated with beclomethasone dipropionate].
    Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Grabski W; Tymińska K
    Pneumonol Alergol Pol; 1997; 65(9-10):597-604. PubMed ID: 9489432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
    Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
    Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
    Gutiérrez V; Prieto L; Torres V; Trenor R; Pérez C; Bertó JM; Marín J
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhalation corticosteroid therapy and nonspecific bronchial responsiveness enhanced with salbutamol].
    Brzostek D; Piotrowska B; Droszcz W
    Pneumonol Alergol Pol; 1994; 62(7-8):375-80. PubMed ID: 7951086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics of different diagnostic tests in adult mild asthmatic patients: comparison with patients with asthma-like symptoms by gastro-oesophageal reflux.
    Di Lorenzo G; Mansueto P; Esposito-Pellitteri M; Ditta V; Castello F; Lo Bianco C; Leto-Barone MS; Di Fede G; Traverso M; Rotolo G; Vigneri S; Rini G
    Respir Med; 2007 Jul; 101(7):1455-61. PubMed ID: 17360170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?
    den Otter JJ; Reijnen GM; van den Bosch WJ; van Schayck CP; Molema J; van Weel C
    Br J Gen Pract; 1997 Aug; 47(421):487-92. PubMed ID: 9302787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eosinophil count in asthma. A marker of disease activity in intrinsic and extrinsic asthma].
    Ulrik CS
    Ugeskr Laeger; 1996 Jun; 158(25):3612-6. PubMed ID: 8693621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic measures: pulmonary function tests. Asthma outcome.
    Enright PL; Lebowitz MD; Cockroft DW
    Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 2):S9-18; discussion S19-20. PubMed ID: 8298772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of validity of different asthma diagnostic tools in adults.
    Yurdakul AS; Dursun B; Canbakan S; Cakaloğlu A; Capan N
    J Asthma; 2005 Dec; 42(10):843-6. PubMed ID: 16393722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
    Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the relationship between the clinical course of severe asthma and ventilatory parameters].
    Tymińska K; Kwiatkowska S; Zieba M; Kroczyńska-Bednarek J; Zagdańska R; Pietrzkowicz M; Grzelewska-Rzymowska I
    Pol Merkur Lekarski; 2000 Oct; 9(52):653-5. PubMed ID: 11144050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the bronchodilator effect of inhaled fenoterol and aerosol salbutamol in patients with chronic bronchial asthma].
    Valdés Cuadrado L; Salgueiro Rodriguez M; Alvarez-Calderón Prat P; Arias Castells MR; Berdugo Oviedo M; Rabuñal Rey R; Ventosa Rial J; Rodríguez Suarez JR
    An Med Interna; 1989 Feb; 6(2):74-8. PubMed ID: 2491076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of efficacy and tolerance of an antiasthmatic preparation--Ditec, consisting of low doses of disodium cromoglycate and fenoterol].
    Siergiejko Z; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1996; 64(11-12):758-65. PubMed ID: 9162320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of fenoterol, ipratropium bromide and combination drug-berodual-on selected clinical parameters and lung function in patients with asthma].
    Rutkowski R; Kazberuk M; Siergiejko Z; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1994; 62(7-8):358-64. PubMed ID: 7951083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma.
    Ulrik CS
    Clin Exp Allergy; 1995 Sep; 25(9):820-7. PubMed ID: 8564720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.